Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opiant Pharmaceuticals
Opiant Pharmaceuticals
New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval
Stat
Mon, 05/22/23 - 10:09 pm
Opiant Pharmaceuticals
Opvee
FDA
opioid overdose
opioids
Fentanyl
Naloxone
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Fierce Pharma
Mon, 01/30/23 - 10:41 am
Elizabeth Warren
Senate
FTC
M&A
Amgen
Horizon Therapeutics
Indivior
Opiant Pharmaceuticals
Indivior inks $145M Opiant buyout to add nasal opioid overdose drug to portfolio
Fierce Pharma
Tue, 11/15/22 - 10:58 am
Indivior
Opiant Pharmaceuticals
M&A
nalmefene
opioid overdose
Opiant beats path to FDA after nasal overdose drug matches Narcan
Fierce Pharma
Tue, 05/3/22 - 10:50 am
Opiant Pharmaceuticals
opioids
opioid overdose
Narcan
FDA
Narcan Creator Takes on Synthetic Opioid Overdoses with Experimental Nasal Spray
BioSpace
Thu, 07/15/21 - 10:51 am
Opiant Pharmaceuticals
Narcan
synthetic opioids
OPNT003
opioid overdose
Opiant’s Mid-Stage Treatment for a Severe Eating Disorder Fails to Reach Endpoints
BioSpace
Fri, 02/22/19 - 11:43 am
Opiant Pharmaceuticals
bulimia nervosa
eating disorders
Narcan
California-Based Opiant Licenses Synthetic Cannabinoid Overdose Drug From Sanofi for $500,000
BioSpace
Fri, 12/28/18 - 01:19 pm
Opiant Pharmaceuticals
Sanofi
cannabinoid overdose
drinabant